U.S. Bioscience regulatory update

U.S. Bioscience Inc. (UBS) The FDA's Oncologic Drug Advisory Committee will evaluate UBS's Ethyol (amifostine) cytoprotective agent on June 9. The West Conshohocken, Penn., company resubmitted an ame...